We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Magnetic Sphincter Augmentation Aids GERD Management

By HospiMedica International staff writers
Posted on 27 Aug 2020
A new study suggests magnetic sphincter augmentation (MSA) is associated with favorable clinical outcomes in gastroesophageal reflux disease (GERD), particularly in younger patients.

Researchers at Allegheny Health Network (Pittsburgh, PA, USA) conducted a retrospective review of prospectively collected data involving of 553 patients who underwent MSA with the Ethicon Endo-Surgery (Ethicon, Cincinnati, OH, USA) LINX device. More...
Preoperative clinical, endoscopic, manometric, and pH data were analyzed to determine factors predicting a favorable outcome, which was defined as freedom from proton pump inhibitor (PPI) use and a higher than 50% improvement in GERD Health-Related Quality of Life (GERD-HRQL) total score.

The results showed that at 10 month follow-up, 92.7% of the patients were free of PPI use, and 84% reported at least 50% improvement in their GERD-HRQL total score, from a mean baseline value of 33.8 to 7.2; 76.1% of the patients had normalization of esophageal acid exposure. Independent predictors of a favorable outcome after MSA included age younger than 45 years, male sex, GERD-HRQL total score higher than 15, and abnormal DeMeester score. The study was published in the May 2020 issue of the Journal of the American College of Surgery (JACS).

“Patients reported significant improvement in GERD health-related quality of life after MSA implantation and about 90% of them discontinued daily use of anti-acid medications,” said lead author Shahin Ayazi, MD. “The finding of younger age as a predictor of successful outcome highlights the importance of early surgical intervention in the management of reflux disease.”

The LINX MSA is made of a series of titanium beads with a magnetic core, connected together with independent titanium wires so as to form a ring that is wrapped around the lower esophageal sphincter (LES). The magnetic forces between the beads help keep the weakened LES closed, preventing reversed flow of stomach contents. When eating, the magnetic forces are overcome by the higher pressures of swallowing forces, and the device expands to accommodate food or liquid. Once food passes though the LES, the device returns to its resting state.

Related Links:
Allegheny Health Network
Ethicon Endo-Surgery



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new 3D heart mapping system visualizes all four chambers in real time (Photo courtesy of UPV)

Whole-Heart Mapping Technology Provides Comprehensive Real-Time View of Arrhythmias

Cardiac arrhythmias can be difficult to diagnose and treat because current mapping systems analyze the heart one chamber at a time. This fragmented view forces clinicians to infer electrical activity they... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.